Investor Relations

Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.

  1. Sep 23, 2025

    2025 Interim Results Online Conference

  2. Apr 02, 2025

    2024 Annual Results Online Conference

  3. Aug 28, 2024

    2024 Interim Results Online Conference

  4. Mar 28, 2024

    2023 Annual Results Online Conference

  5. Dec 15, 2023

    HBM 9033 Out-license to Pfizer